Drug
AB Sa01
AB Sa01: highest development phase Phase 1, developed by Armata Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Armata Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| AB-SA01 (10^8 PFU per phage) NCT02757755 | Phase 1 | Healthy Volunteers |
Latest
No recent events.
Follow AB Sa01 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.